# Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau Test

> **NCT04812938** · — · UNKNOWN · sponsor: **Azienda Ospedaliera San Giovanni Battista** · enrollment: 190 (estimated)

## Conditions studied

- Ovarian Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Patients with Ovarian cancer and pap test available

## Key facts

- **NCT ID:** NCT04812938
- **Lead sponsor:** Azienda Ospedaliera San Giovanni Battista
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-12
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 190 (ESTIMATED)
- **Last updated:** 2021-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04812938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04812938, "Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau Test". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04812938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*